ImmunoCellular Therapeutics, Ltd.·4

Jun 8, 4:07 PM ET

Yu John S 4

4 · ImmunoCellular Therapeutics, Ltd. · Filed Jun 8, 2018

Insider Transaction Report

Form 4
Period: 2018-06-06
Yu John S
DirectorSecretary
Transactions
  • Award

    Common Stock

    2018-06-06+120,000120,250 total
Holdings
  • Common Stock

    (indirect: By Trust)
    258
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of ImmunoCellular Therapeutics Ltd. common stock.
  • [F2]The restricted stock unit shall be fully vested and immediately exercisable on the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION